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Abstract
Vitamin D status has been associated with cardiometabolic markers even in children, but the associations may be confounded by fat mass and
physical activity behaviour. This study investigated associations between vitamin D status and cardiometabolic risk proﬁle, as well as the
impact of fat mass and physical activity in Danish 8–11-year-old children, using baseline data from 782 children participating in the Optimal
well-being, development and health for Danish children through a healthy New Nordic Diet (OPUS) School Meal Study. We assessed
vitamin D status as serum 25-hydroxyvitamin D (25(OH)D) and measured blood pressure, fasting plasma glucose, homoeostasis model of
assessment-insulin resistance, plasma lipids, inﬂammatory markers, anthropometry and fat mass by dual-energy X-ray absorptiometry, and
physical activity by 7 d accelerometry during August–November. Mean serum 25(OH)D was 60·8 (SD 18·7) nmol/l. Each 10 mmol/l 25(OH)D
increase was associated with lower diastolic blood pressure (−0·3mmHg, 95 % CI −0·6, −0·0) (P= 0·02), total cholesterol (−0·07 mmol/l,
95 % CI −0·10, −0·05), LDL-cholesterol (−0·05 mmol/l, 95 % CI −0·08, −0·03), TAG (−0·02 mmol/l, 95 % CI −0·03, −0·01) (P≤ 0·001 for all lipids)
and lower metabolic syndrome (MetS) score (P= 0·01). Adjustment for fat mass index did not change the associations, but the association with
blood pressure became borderline signiﬁcant after adjustment for physical activity (P= 0·06). In conclusion, vitamin D status was negatively
associated with blood pressure, plasma lipids and a MetS score in Danish school children with low prevalence of vitamin D deﬁciency, and
apart from blood pressure the associations were independent of body fat and physical activity. The potential underlying cause–effect
relationship and possible long-term implications should be investigated in randomised controlled trials.
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Vitamin D status is assessed by the concentration of serum
25-hydroxyvitamin D (25(OH)D), a circulating vitamin D
metabolite(1). Humans obtain vitamin D from exposure to
sunlight and through vitamin D intake, with sunlight being
the primary source(1). Vitamin D facilitates intestinal Ca
absorption(2,3), and severe deﬁciency is detrimental to childhood
bone health(4). In addition, vitamin D status in childhood has
been inversely associated with cardiometabolic risk markers such
as glucose, insulin and blood pressure(5). These associations
have been suggestively explained by a potential favourable role
of active vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)2D), in
cardiometabolic mechanisms such as blood pressure regulation
through the renin–angiotensin system(6), pancreatic β-cell function
and protection(7,8), and low-grade inﬂammation suppression(9,10), as
well as by an inverse association with parathyroid hormone (PTH),
an apparent predictor of inﬂammation, dyslipidaemia and cardio-
vascular calciﬁcations in obese children and adolescents(11,12).
Excess body weight and fat mass in childhood increase the
risk of the metabolic syndrome (MetS), a cluster of elevated risk
factors including insulin resistance, high blood pressure,
deranged lipid proﬁle and abdominal obesity, that has been
associated with CVD risk in adults(13,14). BMI is consistently
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inversely associated with vitamin D status in adults(15). This
association has also been demonstrated in overweight and
obese children(16–18), and in American and Spanish children of
primarily normal weight(19–22), although not all studies
agree(23,24). Relations between vitamin D status and cardio-
metabolic risk markers may be mediated or confounded by fat
mass, which in turn may be associated with vitamin D status
through sequestering of vitamin D in adipose tissue(25) or by
reverse causality – that is, through poorer diets and less sun
exposure in overweight subjects leading to lower vitamin D
status. Therefore, adjustment for the potential confounding
effects of fat mass is important when evaluating associations
between vitamin D status and cardiometabolic health. Most
studies in children have used BMI, which does not convey
information on body composition, and more sophisticated
measurements of body fat are called for in observational
studies(25). Moreover, as physical activity, especially of
moderate-to-vigorous physical activity (MVPA), has been asso-
ciated both with cardiometabolic risk markers(26) and with
increased sun exposure and vitamin D status in children(27), it
should be considered a potential confounder.
The aim of this cross-sectional study was to (1) investigate
associations between vitamin D status and cardiometabolic risk
markers, and (2) investigate whether these associations were
independent of objectively measured fat mass index (FMI) and
physical activity, in a large cohort of Danish 8–11-year-old
school children.
Methods
Study design and participants
The present study used cross-sectional baseline data from the
Optimal well-being, development and health for Danish children
through a healthy New Nordic Diet (OPUS) School Meal Study, a
large cluster-randomised controlled cross-over trial including
third- and fourth-grade children from nine schools in Denmark.
The primary aim of the OPUS School Meal Study was to evaluate
the impact of school meals based on the New Nordic Diet on a
MetS score and cognitive concentration performance, as pre-
viously described(28). Brieﬂy, initial contact was established with
thirty-nine schools whereof nine schools, located in eight separate
urban and rural municipalities, were included. Inclusion criteria for
the schools were (a) location in the eastern part of Denmark;
(b) a total of four or more classes at third and fourth grade;
(c) suitable kitchen facilities available for food production during
school days; and (d) a high motivation for participation as deter-
mined by the study team. Written information about the study was
sent to the families of all 1021 third- and fourth-grade children at
the schools. To recruit families of various socioeconomic and
ethnic backgrounds, we held several information meetings at each
school; sent out several reminders; and had translators present at
meetings when relevant. Exclusion criteria for the children were
(a) diseases or conditions that might obstruct the measurements or
put a child at risk by eating the intervention school meals, or
(b) concomitant participation in other studies that involved radia-
tion or blood sampling. Written informed consent for participation
was obtained from the custody holders of 834 children (82%).
The study was conducted in accordance with the Declaration of
Helsinki, and the study protocol was approved by the Committees
on Biomedical Research Ethics for the Capital Region of
Denmark (H-1-2010-124) and registered with clinicaltrials.gov
(NCT 01577277).
Questionnaires
Information on demographic and socioeconomic characteristics
was collected by an in-depth 2 h personal interview with the
child and parents. On the basis of the highest education level
attained in the household, parental education level was cate-
gorised as lower secondary education (≤10 years of schooling),
upper secondary education, vocational education, short higher
education, bachelor’s degree or equivalent or ≥master’s degree
(≥17 years of schooling). Children were categorised as immi-
grants/descendants if all grandparents and ≥1 parent were
born outside Denmark. This classiﬁcation was inspired by the
deﬁnitions of immigrants and descendants used by Statistics
Denmark(29), although not identical as citizenship was not
available in the present study. Pubertal status was self-evaluated
by the child based on breast development in girls and pubic
hair in boys (Tanner stages)(30). Registrations were dichoto-
mised into a variable indicating entered puberty (yes/no).
Recordings of dietary intake and physical activity
During the weeks before the clinical examination, children,
aided by their parents, recorded their daily intake of food and
beverages for 7 consecutive days using a Web-based Dietary
Assessment Software for Children. The software was developed
speciﬁcally for children aged 8–11 years and validated in the
OPUS School Meal Pilot Study(31,32). Intake data were processed
as previously described(31). Energy intake (EI) relative to esti-
mated BMR was evaluated following the equations by
Henry(33), and energy under-reporters (EI/BMR≤ 1·05) and
over-reporters (EI/BMR≥ 2·28)(34) were excluded from the
dietary variables, as were children who registered their diet for
<4 d. Intake of dietary supplements was registered and a
dichotomous variable was formed, indicating whether the child
had ingested any kind of vitamin D-containing dietary supple-
ments, including multivitamins, during the dietary registration
week. To measure physical activity, the children were
asked to wear an accelerometer (ActiGraph GT3X+ Tri-Axis
Accelerometer Monitor) in an elastic belt tightly fastened at the
right hip for the same 7 d and eight nights as the dietary
recordings, and to remove it only during water activities – that
is, showering or swimming. Analyses of the physical activity
data were described in detail previously(35). We used time spent
with MVPA, deﬁned as ≥2296 vertical counts/min(36), as the
measure of physical activity, as this has shown stronger
associations with cardiometabolic risk markers(26) than total
physical activity (counts/min) in children.
Clinical measurements and blood sampling
Clinical measurements and blood sampling were conducted
from 30 August to 28 November 2011 during morning hours at
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each school, as previously described(37). Children had been
fasting since midnight, had voided and were wearing only light
clothing. Height was measured to the nearest one decimal using
a transportable stadiometer (CMS Weighing Equipment Ltd).
Height was derived as the mean of three consecutive mea-
surements with the child in standing position and holding his
head in the Frankfurter plane and body weight was measured
using a digital scale (BWB 800 S; Tanita). BMI was calculated as
body weight (kg) divided by height (m2), and sex-adjusted and
age-adjusted Z-scores for BMI were calculated using the WHO
AnthroPlus software(38). Children were categorised as under-
weight, normal weight, overweight and obese on the basis of
age- and sex-speciﬁc cut-offs deﬁned to pass through BMI of
18·5, 25 and 30 kg/m2 at the age of 18 years, as described
by Cole et al.(39,40). Waist circumference was measured in
centimetres to the nearest millimetre using a non-elastic
measuring tape at the level of the umbilicus, and the mean of
three consecutive measurements was used. Total body fat mass
was determined by dual-energy X-ray absorptiometry (DXA)
scanning (Lunar Prodigy ProTM; GM Healthcare) with EnCor-
eTM software. FMI was calculated as total fat mass divided by
height squared. In addition, the investigator recorded the
apparent ethnicity of the child by applying the terminology of
the DXA software – that is, Caucasian, Asian, African, Latin or
Other. Children from Turkey, the Middle East, Pakistan and
India were recorded as Caucasians. Because of small categories,
a dichotomised variable indicating whether or not the child was
Caucasian (yes/no) was used.
Blood pressure and heart rate were measured by an auto-
mated device (UA-787 Plusl; A&D Medical) after 10 min of rest
using two different cuff sizes (18–22 or 22–32 cm). A second
device (ProBP 3400 Sure BP; Welch Allyn Inc.) was used for
children with arm circumferences <18 cm. Measurements were
performed three times whereof the mean of the last two
measurements was used. Thereafter, fasting blood was sampled
from the forearm by venepuncture. Local anaesthetic patches
were offered to the children to reduce discomfort of blood
sampling.
Blood analyses
Whole-blood glucose concentrations were analysed immedi-
ately after sampling (Glucose 201; Hemocue Danmark).
Twenty-four glucose samples were removed from the analyses
because they were obtained from non-fasting children. Hepar-
inised blood and blood with EDTA were centrifuged at 2500 g
for 10 min at room temperature, and plasma was stored at
−80°C for batch analysis of total, LDL and HDL-cholesterol,
TAG, IL-6 and adiponectin. Blood collected in serum tubes
with gel was centrifuged after 30 min of coagulation at room
temperature, and it was stored at −80°C for later batch analysis
of insulin, 25(OH)D and intact PTH. For each analysis, all
samples were ran on the same device with the same reagent lot,
all samples from each child were analysed on the same day and
all samples from one school were analysed in one assay.
Cholesterols and TAG were quantiﬁed on the Vitros 5·1 FS
analyser (Ortho-Clinical Diagnostics, Johnson & Johnson).
LDL-cholesterol was calculated using Friedewalds’s
equation(41). Plasma high-sensitivity IL-6 and adiponectin were
measured in duplicate by ELISA (R&D Systems Europe Ltd), and
serum insulin was quantiﬁed on ADVIA Centaur XP (Siemens
Healthcare). Homoeostasis model of assessment of insulin
resistance (HOMA-IR) was calculated as plasma glucose
(mmol/l)× serum insulin (mIU/l)/22·5(42), with insulin
concentrations converted from pmol/l to mIU/l by dividing by
6·945. Twenty-three insulin and HOMA-IR samples were
removed from the analyses because they were obtained from
non-fasting children.
Vitamin D status was measured as serum 25(OH)D
concentrations (including both D2 and D3) by an automated
chemiluminescent immunoassay on DiaSorin LIAISON
(DiaSorin AB) at the Department of Clinical Biochemistry,
Aalborg University Hospital, Aalborg, Denmark, a laboratory
partaking in the vitamin D external quality assessment scheme
(DEQAS)(43). During the serum 25(OH)D analysis period (May
to September 2012), the DEQAS quality control showed that our
analysis had a negative bias of up to 30·6 % compared with the
all laboratory trimmed means (ALTM) and a bias of 2·3–14·5 %
compared with the means of laboratories using the same
method as we used (method mean). Accordingly, the results of
the laboratory are always within 2 SD but mostly within 1 SD of
ALTM with a tendency to be slightly lower. Before analysis,
serum was thawed at room temperature for 30 min before being
centrifuged at 4000 rpm for 3 min. Concentrations are presented
in nmol/l (1 nmol/l= 0·4006 ng/ml), and lowest detection limit
was 10 nmol/l. Vitamin D deﬁciency and insufﬁciency was
deﬁned as serum 25(OH)D concentrations <25 and ≤50 nmol/l,
as recommended by the European Society for Paediatric
Gastroenterology, Hepatology and Nutrition(44).
Serum intact PTH concentrations were determined by
a chemiluminescent immunoassay on ADVIA Centaur XP
(Siemens Healthcare). Lowest detection limit was 0·265 pmol/l.
One sample had PTH concentration below the detection limit of
0·265 pmol/l; this sample was deﬁned as half of the detection
limit (0·133 pmol/l), and one doubtful PTH value of 109 pmol/l
(25(OH)D at 89·1 nmol/l) was removed from the data set as
extreme outlier.
EPA+DHA in whole blood, a biomarker of ﬁsh and n-3
long-chain PUFA intake, was measured by high-throughput
GC within 3 months after blood sampling, as previously
described(45). The content of individual fatty acids and fatty acid
classes are given in weight% of the total whole-blood fatty
acids.
The inter- and intra-assay CV for the blood analyses were as
follows: 1·4 and 1·2 % (total cholesterol); 2·0 and 1·2 % (HDL-
cholesterol); 1·5 and 0·8 % (TAG); 6·7 and 2·9 % (IL-6); 11 and
3·8 % (adiponectin); 2·5 and 3·1 % (insulin); 5·4 and 7·6 %
(25(OH)D); 7·4 and 7·9 % (PTH); 4·5 and 1·3% (EPA); and 6·4
and 2·4 % (DHA). The inter-assay variation for glucose was 4·0 %.
Metabolic syndrome score and clinically high values
A continuous MetS score was calculated by combining the
Z-scores derived from separate analyses of the ﬁve outcomes:
mean arterial pressure, plasma HDL-cholesterol, plasma TAG,
HOMA-IR and waist circumference. This was based on the
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International Diabetes Federation (IDF) deﬁnition of the
MetS for children ≥10 years of age(13), although we included
HOMA-IR rather than blood glucose because the latter is highly
stable in non-diabetic children, even among obese adolescents
with MetS features(46). In addition, the cut-offs recommended
by the IDF for diagnosing the MetS in ≥10-year-olds were used
in the present study to identify clinically aberrant values of
the individual MetS markers(13). These were ≥130 and ≥85 for
systolic and diastolic blood pressure, respectively; ≥1·7 and
<1·03 mmol/l for TAG and HDL-cholesterol, respectively; and
≥90th percentile for waist circumference, using a recently
published Danish reference material for waist circumference in
children(47). No widely used cut-offs for HOMA-IR have been
deﬁned in children. The cut-off of 2·5 used in adults has been
applied, but as it has been argued that it should be closer to 3 in
growing children of this age(48) the cut-off for HOMA-IR was set
at >2·8 in the present study. For total and LDL-cholesterol,
values ≥200mg/dl (≥5·2mmol/l) and ≥130mg/dl (≥3·4mmol/l)
were deﬁned as elevated, as recommended by the American
Academy of Pediatrics(49).
Statistical analyses
The statistical analyses were carried out using STATA (version
12.1; StataCorp). Assumptions underlying statistical models
were assessed graphically using residual and normal probability
plots, and outcomes were logarithm-transformed as appro-
priate. Signiﬁcance was established at P< 0·05. Descriptive
characteristics of the study sample are presented as means
and standard deviations, medians (25th–75th percentile) or
proportions (%), and sex differences in continuous variables
were tested using the two-sample t test or Wilcoxon–Mann–
Whitney test (non-normally distributed variables), and with the
χ2 test or Fisher’s exact test for categorical variables.
Linear mixed-effects models were used to evaluate associa-
tions between serum 25(OH)D and the cardiometabolic
markers, and in all models school, grade, class and sibling were
included as random effects to account for the dependency
caused by the nested design. Sex, age, height, ethnicity, entered
puberty (yes/no) and parental education were included as ﬁxed
effects, as well as EPA+DHA in whole blood, which has
previously been associated with cardiometabolic health in the
current study population(45). In addition, an interaction term
between sex and puberty was included in the models, but it was
removed if nonsigniﬁcant. In addition, all associations including
blood pressure were adjusted for the blood pressure device
applied.
Additional adjustment for FMI (or BMI-for-age Z-scores),
MVPA, as well as PTH, as potential confounders or mediators
were performed subsequently in those models that had initially
shown signiﬁcant associations between 25(OH)D and cardio-
metabolic markers, by including one covariate at a time.
High colinearity meant that waist circumference and the MetS
score were not adjusted for FMI or BMI Z-scores. All estimated
regression coefﬁcients are presented as outcome response per
10 nmol/l increase in serum 25(OH)D.
Finally, we explored whether serum 25(OH)D was associated
with elevated cardiometabolic values, using logistic regression
analysis. These models included the same ﬁxed effects as
the linear regression models described above. In case of
convergence problems, reduced logistic regression models
were ﬁtted including only class as random effect or no random
effects.
Results
Characteristics of the study population
Of the 834 children originally enroled in the OPUS School Meal
Study, eleven children withdrew before the ﬁrst blood
sampling, seven were ill or on holiday on the day of sampling
and thirty-four children failed to deliver a blood sample or had a
sample with insufﬁcient blood volume for 25(OH)D analysis.
Accordingly, 782 children (93·8 %) were included in the present
study. There were 47·7 girls and 52·3 % boys and most children
(94·7 %) were of Caucasian ethnicity, whereas 2·6, 1·8, 0·8 and
0·1 % were of Asian, Afro-American, Latin-American and other
ethnicities, respectively. As will be published elsewhere
(Rikke A. Petersen, unpublished results), the serum 25(OH)D
concentrations ranged from 15 to 132 nmol/l and concentra-
tions ≤50 nmol/l were observed in 28.4 % of the children,
whereas 2·4 % had concentrations <25 nmol/l. About half of the
children had taken vitamin D-containing supplements during
the dietary registration week. Boys were older, spent more time
on MVPA, had higher intakes of energy, protein, vitamin D and
Ca and higher serum 25(OH)D than girls, whereas more girls
had entered puberty (Table 1). In addition, girls had higher FMI
and higher values of most cardiometabolic markers compared
with boys (Table 2).
Associations between vitamin D status and BMI, fat mass
index, physical activity and parathyroid hormone
Serum 25(OH)D was negatively associated with BMI Z-scores
(P= 0·03) and FMI (P= 0·001) and positively associated with
MVPA (1·21 min/d, 95 % CI 0·29, 2·12/10 nmol/l increase)
(P= 0·010). However, the association with BMI Z-scores
became nonsigniﬁcant when the model was adjusted for
parental education (−0·03, 95 % CI −0·07, −0·001, P= 0·14). In
contrast, the negative association between serum 25(OH)D and
FMI (−0·09 kg/m2, 95 % CI −0·16, −0·02, P= 0·007), as well as
the positive association with MVPA (1·29 min/d (95 % CI
0·36, 2·23, P= 0·007), remained after adjustment for parental
education. Moreover, serum 25(OH)D was negatively asso-
ciated with PTH, corresponding to 0·23 pmol/l (95 % CI 0·16,
0·29, P< 0·001) lower PTH per 10 nmol/l increase in 25(OH)D.
Associations between vitamin D status and cardiometabolic
risk markers
Serum 25(OH)D was negatively associated with diastolic
blood pressure, total and LDL-cholesterol, TAG and the MetS
score, but not with HOMA-IR, systolic blood pressure,
HDL-cholesterol or waist circumference (Table 3). Adjustment
for FMI did not change any of the associations, whereas the
association between serum 25(OH)D and diastolic blood
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Table 1. Characteristics of the study population
(Mean values and standard deviations; median values and 25th, 75th percentiles; percentages)
Girls Boys
Mean SD Mean SD P
Age (years) 9·9 0·6* 10·1 0·6 <0·001
Entered puberty (%) 46·6 23·7 <0·001
Non-Caucasian (%) 4·8 5·7 0·61
Immigrant/descendants (%) 10·7 12·2 0·51
Parental education (% A/B/C/D/E/F) 6/4/33/10/28/19 5/3/31/10/28/23 0·75
BMI-for-age Z-score 0·08 1·04 0·21 1·10 0·08
FMI (kg/m2) <0·001
Median 4·1 3·2
25th, 75th percentile 2·9, 5·7 2·2, 4·9
Weight status (% uw/nw/ow/ob) 11/74/13/2 9/78/11/2 0·50
Month of blood sampling (% August/September/October/November) 2/36/18/44 3/38/19/40 0·58
Serum 25(OH)D (nmol/l) 58·4 18·1 62·9 19·0 <0·001
Whole-blood EPA+DHA (weight %) 3·60 0·98 3·58 0·95 0·68
PTH (pmol/l) 0·02
Median 3·2 3·1
25th, 75th percentile 2·4, 4·2 2·2, 4·0
Moderate-to-vigorous physical activity (min/d) <0·001
Median 37 57
25th, 75th percentile 26, 48 39, 73
Dietary intake
Energy intake (kJ/d) 7210 1174 8290 1406 <0·001
Fat (energy %) 31·9 4·0 32·2 4·3 0·32
Protein (energy %) 15·1 2·1 15·5 2·0 0·02
Carbohydrate (energy %) 53·0 4·6 52·3 4·7 0·06
Ca (mg/d) <0·001
Median 843 953
25th, 75th percentile 684, 1006 796, 1180
Vitamin D (µg/d) <0·01
Median 1·7 2·0
25th, 75th percentile 1·3, 2·6 1·5, 2·9
Vitamin D supplements (% yes)† 55 50 0·24
25(OH)D, 25-hydroxy vitamin D; A, ≤ lower secondary education; B, upper secondary education; C, vocational education; D, short higher education; E, bachelor’s degree or
equivalent; F, ≥master’s degree; nw, normal weight; ob, obese; ow, overweight; PTH, parathyroid hormone; uw, underweight.
* n 756–782; however n 727 for PTH and n 681 for dietary intake.
† Registered intake of vitamin D-containing dietary supplements ≥1 d during the dietary recording week.
Table 2. Cardiometabolic risk markers in the study population
(Mean values and standard deviations; median values and 25th, 75th percentiles)
Girls Boys
n Mean SD Mean SD P
HOMA-IR 721 0·002
Median 1·53 1·35
25th, 75th percentile 1·10, 2·13 0·99, 1·91
Systolic blood pressure (mmHg) 782 107 9 108 8 0·08
Diastolic blood pressure (mmHg) 782 69 7 67 6 <0·001
Total cholesterol (mmol/l) 782 4·11 0·65 4·08 0·66 0·54
LDL-cholesterol (mmol/l) 782 2·37 0·56 2·30 0·58 0.09
HDL-cholesterol (mmol/l) 782 1·40 0·29 1·49 0·32 <0·001
TAG (mmol/l) 782 <0·001
Median 0·66 0·58
25th, 75th percentile 0·54, 0·84 0·48, 0·71
Waist circumference (cm) 782 0·95
Median 62·7 62·6
25th, 75th percentile 59·0, 68·7 59·4, 68·3
Plasma adiponectin (mg/l) 759 0·08
Median 11·3 10·6
25th, 75th percentile 8·3, 14·9 7·7, 14·1
Plasma IL-6 (ng/l) 774 <0·001
Median 0·95 0·80
25th, 75th percentile 0·69, 1·56 0·58, 1·18
MetS score* 744 0·55 3·33 −0·48 2·95 <0·001
HOMA-IR, homoeostasis model of assessment-insulin resistance; MetS: metabolic syndrome.
* Based on mean arterial pressure, HDL-cholesterol, TAG, HOMA-IR and waist circumference (see the ‘Methods’ section).
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pressure became borderline signiﬁcant after adjustment for
MVPA. Adjustment for BMI Z-scores instead of FMI or for PTH
did not change the results (data not shown).
Only ﬁfteen children (1·9 %) had plasma TAG ≥1·7mmol/l.
The same number had high blood pressure deﬁned as ≥130/
85 mmHg, whereas thirty-seven children (4·7 %) had HDL-
cholesterol values <1·03mmol/l. A total of sixty-ﬁve children
(9·0 %) had HOMA-IR >2·8 and 265 children (33·9 %) had a
waist circumference ≥90th percentile(47). Elevated total and
LDL-cholesterol (≥5·2 and ≥3·4 mmol/l, respectively) were
found in ﬁfty (6·4 %) and thirty-nine (5·0 %) children, respec-
tively. Higher serum 25(OH)D was associated with reduced
odds for high total cholesterol – that is, OR 0·80 (95 % CI 0·66,
0·97) (P= 0·03) per 10 nmol/l increase in serum 25(OH)D. This
was not seen for LDL-cholesterol (P= 0·93) or any of the other
cardiometabolic markers (P> 0·12).
Discussion
This study showed inverse associations between serum
vitamin D status and a number of cardiometabolic risk markers
in a sample of primarily normal weight, healthy children with
low prevalence of vitamin D deﬁciency. To our surprise, the
associations with plasma cholesterols, TAG and the continuous
MetS score were independent of the potential confounding
effects of fat mass and physical activity. The negative associa-
tion with the MetS score was likely driven by TAG and to some
degree by waist circumference, as total and LDL-cholesterol
were not included in the score.
Some previous studies among child populations of fairly
comparable ethnicity, age and body size have also demon-
strated inverse associations between vitamin D status and total
cholesterol(20,50), TAG(50,51), diastolic blood pressure(20,52) and
waist circumference(16), whereas four studies in Canadian,
Spanish, American and British children, respectively, found
no associations with LDL-cholesterol(24,50–52). A study in
149 Spanish children reported an inverse association with TAG,
but not with total cholesterol, after adjustment for age, sex,
BMI and physical activity(51). Whereas associations with
HDL-cholesterol were not found in the present study, positive
associations between serum 25(OH)D and HDL-cholesterol
were reported in large samples of American(20) and British
children(52). In the British study, the association with
HDL-cholesterol, but not that with blood pressure, remained
after adjustment for waist circumference, socioeconomic posi-
tion and other potential confounders(52). None of the studies
investigating associations with plasma lipid proﬁle adjusted for
puberty, which may be an important confounder.
In the present study, vitamin D status was positively
associated with BMI and FMI. However, only the association
with FMI remained after adjustment for parental education. This
indicates that socioeconomic differences may indeed be
confounding the association with BMI, probably through an
effect on behaviours related to both vitamin D exposure and
being overweight. However, in line with the persisting
association with FMI in the present study, a randomised
controlled trial in African-American children reported that the
serum 25(OH)D response to vitamin D supplementation was
consistently inversely correlated with baseline total body fat
mass(53). Similarly, an American vitamin D supplementation trial
in Caucasian adolescents found increments in 25(OH)D con-
centrations to be lower in obese compared with non-obese
adolescents(54), indicating that vitamin D sequestering in
adipose tissue may indeed have a role.
We showed that associations between vitamin D status and
blood pressure and plasma lipids were independent of fat mass
and BMI, indicating potential independent mechanisms. It has
been demonstrated that the active metabolite of vitamin D,
1,25(OH)2D, can upregulate lipoprotein lipase in vitro,
thereby potentially playing a beneﬁcial role in lipoprotein
metabolism(55). However, causality cannot be inferred from the
present study, and to our knowledge no randomised controlled
trials have investigated the effect of vitamin D supplementation
on plasma lipids in children. A non-randomised study
Table 3. Associations between serum 25-hydroxy vitamin D (25(OH)D) and cardiometabolic risk markers
(β Coefficients and 95% confidence intervals)
25(OH)D 25(OH)D adjusted for FMI 25(OH)D adjusted for MVPA
β 95% CI* P β 95% CI* P β 95% CI* P
HOMA-IR −0·02 −0·06, 0·00 0·12 – – – –
Systolic blood pressure (mmHg) −0·2 −0·6, 0·1 0·22 – – – –
Diastolic blood pressure (mmHg) −0·3 −0·6, −0·0 0·02 −0·3 −0·6, −0·0 0·04 −0·3 −0·5, 0·0 0·06
Total cholesterol (mmol/l) −0·07 −0·10, −0·05 <0·001 −0·07 −0·10, −0·04 <0·001 −0·08 −0·10, −0·05 <0·001
LDL-cholesterol (mmol/l) −0·05 −0·08, −0·03 <0·001 −0·05 −0·07, −0·02 <0·001 −0·06 −0·08, −0·03 <0·001
HDL-cholesterol (mmol/l) −0·01 −0·02, 0·00 0·15 – – – –
TAG (mmol/l) −0·02 −0·03, −0·01 0·001 −0·01 −0·02, −0·01 0·003 −0·02 −0·03, −0·01 0·001
Waist circumference (cm)† −0·24 −0·51, 0·03 0·09 – – – –
MetS score†‡ −0·16 −0·28, −0·03 0·01 – – – −0·13 −0·25, 0·00 0·047
Adiponectin (mg/l) 102 −124, 328 0·38 – – – –
IL-6 (ng/l) 0·01 −0·02, 0·04 0·49 – – – –
FMI, fat mass index; HOMA-IR, homoeostasis model of assessment-insulin resistance; MetS, metabolic syndrome; MVPA, moderate-to-vigorous physical activity (min/d).
* Mixed linear models, all adjusted for sex, age, height, ethnicity, whole-blood EPA+DHA, entered puberty (yes/no) and parental education. Regression coefficients are presented
as cardiometabolic outcome response per 10 nmol/l increase in serum 25(OH)D.
† Because of high risk of colinearity, waist circumference and the MetS score were not adjusted for FMI.
‡ Based on mean arterial pressure, plasma HDL-cholesterol, plasma TAG, HOMA-IR and waist circumference.
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supplementing seventy Argentine Indian school children with
5000 IU (125 µg/d) vitamin D for 8 weeks showed that HDL-
cholesterol measured after 1 year was increased compared with
a group of twenty unsupplemented children(56). In contrast with
the present study, the study population had high prevalence
of vitamin D deﬁciency – that is, 20 % of the children had serum
25(OH)D <25 nmol/l. With regard to blood pressure, there is
some evidence, especially from vitamin D receptor knockout
mice, that vitamin D can reduce blood pressure through inhi-
bition of the renin–angiotensin system(6). Other suggested
mechanisms include regulation of vascular tone by 1,25(OH)D
by facilitating Ca inﬂux to the muscle cells and direct effects on
vascular endothelium and smooth muscle cells(57) – for exam-
ple, through regulation of transcription of endothelial nitric
oxide synthase, which has been demonstrated in vitro(58).
However, the association between vitamin D status and blood
pressure was somewhat confounded by physical activity in the
present study. This indicates that behaviours related to both
vitamin D exposure and blood pressure rather than biological
mechanisms may be responsible for the association. To our
knowledge, only the single-blinded randomised controlled trial
in forty-nine African-American adolescents has investigated the
effects of vitamin D on blood pressure. The participants, who
had a mean serum 25(OH)D of 33·4 nmol/l at baseline, were
randomised to 2000 IU/d (50 µg/d) or 400 IU/d (10 µg/d)
(control) vitamin D for 16 weeks from February to May.
Although carotid-femoral pulse-wave velocity increased in the
control group and decreased in the high-dose vitamin D group,
no changes or differences were seen in systolic or diastolic
blood pressure(53). Meta-analyses of randomised trials in adults
show no or little effect of vitamin D on blood pressure. Witham
et al.(59) included eleven randomised controlled vitamin D trials
of mainly older subjects and found a small reduction in diastolic
blood pressure (−3·1mmHg, 95 % CI −5·5, −0·6) among the
eight studies in hypertensive subjects only. However, as most
studies were relatively small (less than sixty subjects) and sig-
niﬁcant heterogeneity was present for the subgroup analyses,
the reliability of these ﬁndings is unclear. This area calls for
further investigation, especially in children.
MVPA was also positively associated with vitamin D status in
the present study, something that has previously been observed
in Korean school children of similar age(27). In the present
study, this level of physical activity could be hypothesised to be
a proxy for sun exposure because of the outdoor nature of
much MVPA during the period from August to November where
data were collected. Indeed, positive associations have been
observed between outdoor engagement and physical activity in
the OPUS School Meal Study(35) and among other children of
this age(60,61). Physical activity could also be a proxy for a
particular lifestyle and an eating pattern with higher intake of
ﬁsh (the main food source of vitamin D in Danes), as has been
demonstrated in previous studies among children(62,63). In
addition, we have recently shown that n-3 long-chain PUFA in
blood, a biomarker of ﬁsh intake, was cross-sectionally
associated with cardiometabolic risk markers in the OPUS
School Meal Study(45). However, the presented results were
adjusted for this biomarker. Finally, although we found a strong
inverse association between PTH and vitamin D status in the
present study, the observed associations between vitamin D
status and the cardiometabolic markers did not appear to be
mediated by PTH.
To our knowledge, this is the ﬁrst study of its kind among
children from the Nordic countries. Vitamin D status was
measured solely during autumn and early winter months, a time
of year when vitamin D status is expected to be close to annual
peak in Danish children. Still, about every fourth child had
serum 25(OH)D status ≤50 nmol/l. A limitation to autumn
25(OH)D measurements is that they are likely inﬂuenced by
recent sun behaviour including sunny vacations abroad, which
were not recorded in the study. However, a recent study in
Danish girls showed that the 25(OH)D concentrations attained
during summer were strong predictors of vitamin D status the
following winter(64). The explorative nature of the study
requested multiple testing and the results must naturally be
interpreted with this in mind. In addition, although we were
able to adjust for important potential confounders such as
pubertal status, ethnicity and the biomarker of ﬁsh intake, there
is always a risk of residual confounding in cross-sectional stu-
dies such as the present one. However, the robust ﬁndings
throughout the adjustments and the consistently low P values
for the plasma lipids do not suggest random ﬁndings. It is a
great strength that the study included DXA scans and 7 d
accelerometry measurements, as these provided validated and
objective measurements of body fat and physical activity. The
observed associations were of small magnitude, and although
higher serum 25(OH)D was associated with reduced odds
for high total cholesterol values this was not the case for
HDL-cholesterol or TAG. Therefore, the immediate clinical
relevance is uncertain. However, plasma lipid levels and blood
pressure have been shown to track from childhood to adult-
hood(65) and children with the MetS in childhood are more
likely to have the MetS as adults(66). This indicates that from a
population perspective slightly lower levels of the cardiometa-
bolic risk markers may give long-term beneﬁt, if sustained over
years. In line with this, higher serum 25(OH)D seemed to be
associated with more beneﬁcial HDL-cholesterol, TAG and
MetS scores over the entire range of values in the present study,
rather than having a speciﬁc impact on the proportion of
aberrant values. There is no uniformly used set of cut-offs for
cardiometabolic risk markers in children, and the various cut-offs
for aberrant values should be used and interpreted with caution.
The very high proportion of children with waist circumference
above the 90th percentile in the present study, despite the use of a
recently published Danish reference material(47), is hard to
explain, but it may relate to the fact that we measured waist cir-
cumference at the level of the umbilicus, whereas the reference
study measured parallel to the ﬂoor at the midpoint between the
ribs and the top of the iliac crest.
In conclusion, vitamin D status was negatively associated
with a number of cardiometabolic markers in Danish school
children with low prevalence of vitamin D deﬁciency, and
apart from blood pressure the associations were independent
of body fat and physical activity. The potential underlying
cause–effect relationship and possible long-term health impli-
cations should be investigated further in randomised controlled
trials.
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